# Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

> **NCT00544050** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 13 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00544050
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544050, "Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00544050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*